These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16850577)

  • 21. Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
    Saito M; Takada M; Hirooka K; Isobe F; Yasumura Y
    J Clin Pharm Ther; 2005 Dec; 30(6):603-10. PubMed ID: 16336294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The efficacy and tolerability of fosinopril in Chinese type 2 diabetic patients with moderate renal insufficiency.
    Tong PC; Ko GT; Chan WB; Ma RC; So WY; Lo MK; Lee KF; Ozaki R; Chow CC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 May; 8(3):342-7. PubMed ID: 16634995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of an ACE inhibitor or angiotensin receptor blocker on potassium in CAPD patients.
    Phakdeekitcharoen B; Leelasa-nguan P
    Am J Kidney Dis; 2004 Oct; 44(4):738-46. PubMed ID: 15384026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversible impairment of renal function associated with enalapril in a diabetic patient.
    Albareda MM; Corcoy R
    CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversible hyperkalemia during antihypertensive therapy in a hypertensive diabetic patient with latent hypoaldosteronism and mild renal failure.
    Uchida K; Azukizawa S; Nakano S; Kaneko M; Kigoshi T; Morimoto S; Matsui A
    South Med J; 1994 Nov; 87(11):1153-5. PubMed ID: 7973905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FOSIDIAL: a randomised placebo controlled trial of the effects of fosinopril on cardiovascular morbidity and mortality in haemodialysis patients. Study design and patients' baseline characteristics.
    Zannad F; Kessler M; Grünfeld JP; Thuilliez C;
    Fundam Clin Pharmacol; 2002 Oct; 16(5):353-60. PubMed ID: 12602460
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fosinopril. A review of its pharmacology and clinical efficacy in the management of heart failure.
    Davis R; Coukell A; McTavish D
    Drugs; 1997 Jul; 54(1):103-16. PubMed ID: 9211084
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperkalemia with enalapril in advanced renal failure.
    Izzo JL; Larrabee PS; Scandling JD
    JAMA; 1986 May; 255(19):2605-6. PubMed ID: 3009908
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy with angiotensin-converting enzyme inhibitors and indapamide impairs glucose tolerance in Chinese hypertensive patients.
    Zhang JL; Qin YW; Zheng X; Qiu JL; Zhao XX; Zou DJ
    Blood Press; 2010 Apr; 19(2):110-8. PubMed ID: 20053144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A prospective, randomized, open labeled crossover trial of fosinopril and theophylline in post renal transplant erythrocytosis.
    Trivedi H; Lal SM
    Ren Fail; 2003 Jan; 25(1):77-86. PubMed ID: 12617335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin Converting Enzyme Inhibitor Dialyzability and Outcomes in Older Patients Receiving Hemodialysis.
    Weir MA; Fleet JL; Dixon SN; Jain AK; Oliver M; Wald R; McIntyre C; Garg AX
    Blood Purif; 2015; 40(3):232-42. PubMed ID: 26382240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Angiotensin converting enzyme inhibitors and pulmonary hypertension.
    Martiniuc C; Braniste A; Braniste T
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(4):1016-20. PubMed ID: 23700881
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparison of the antihypertensive activity of fosinopril and irbesartan].
    Angulo E; Robles NR; Grois J; Barquero A; Pérez Miranda M
    An Med Interna; 2002 Nov; 19(11):571-5. PubMed ID: 12522893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of enalapril and nifedipine on orthostatic hypotension in older hypertensive patients.
    Slavachevsky I; Rachmani R; Levi Z; Brosh D; Lidar M; Ravid M
    J Am Geriatr Soc; 2000 Jul; 48(7):807-10. PubMed ID: 10894321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation.
    Di Salvo G; Castaldi B; Gala S; Baldini L; Del Gaizo F; D'Aiello FA; Mormile A; Rea A; Scognamiglio G; Pacileo G; Keating S; Fadel BM; Berrino L; Perna A; Russo MG; Calabrò R
    J Hum Hypertens; 2016 Jun; 30(6):363-7. PubMed ID: 26290275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
    Schmidt A; Gruber U; Böhmig G; Köller E; Mayer G
    Nephrol Dial Transplant; 2001 May; 16(5):1034-7. PubMed ID: 11328912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.
    Sarro GD; Paola ED; Gratteri S; Gareri P; Rispoli V; Siniscalchi A; Tripepi G; Gallelli L; Citraro R; Russo E
    Pharmacol Res; 2012 Mar; 65(3):285-96. PubMed ID: 22107891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of fosinopril on progression of the asymptomatic carotid atherosclerosis and left ventricular hypertrophy in hypertensive patients].
    Tasić IS; Mijalković D; Djordjević D; Lović B; Janković D; Miladinović-Tasić N; Lović M
    Srp Arh Celok Lek; 2006; 134(3-4):106-13. PubMed ID: 16915750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ramipril and risk of hyperkalemia in chronic hemodialysis patients.
    Krajina-Andricević M; Zibar L; Juras K; Goll-Barić S; Barbić J
    Coll Antropol; 2011 Jun; 35(2):537-42. PubMed ID: 21755729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.